TY  - GEN
AU  - Cameron,D A
AU  - Camidge,D R
AU  - Oyee,J
AU  - Hirsch,M
TI  - Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer
SN  - 1532-1827
PY  - 2009///0102
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Estradiol
KW  - Fulvestrant
KW  - Hormone Replacement Therapy
KW  - Humans
KW  - Neoplasm Staging
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Substrate Specificity
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bjc.6604790
ER  -